Skip to main content

Patient-reported use of marijuana and cannabinoid (CBD) oil in patients with renal cell carcinoma undergoing systemic therapy.

Publication ,  Conference
Battle, D; Bergerot, CD; Msaouel, P; Zhang, T; George, DJ; Staehler, MD
Published in: JOURNAL OF CLINICAL ONCOLOGY
2020

Duke Scholars

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

2020

Volume

38

Issue

15

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Battle, D., Bergerot, C. D., Msaouel, P., Zhang, T., George, D. J., & Staehler, M. D. (2020). Patient-reported use of marijuana and cannabinoid (CBD) oil in patients with renal cell carcinoma undergoing systemic therapy. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 38).
Battle, Dena, Cristiane Decat Bergerot, Pavlos Msaouel, Tian Zhang, Daniel J. George, and Michael D. Staehler. “Patient-reported use of marijuana and cannabinoid (CBD) oil in patients with renal cell carcinoma undergoing systemic therapy.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 38, 2020.
Battle D, Bergerot CD, Msaouel P, Zhang T, George DJ, Staehler MD. Patient-reported use of marijuana and cannabinoid (CBD) oil in patients with renal cell carcinoma undergoing systemic therapy. In: JOURNAL OF CLINICAL ONCOLOGY. 2020.
Battle D, Bergerot CD, Msaouel P, Zhang T, George DJ, Staehler MD. Patient-reported use of marijuana and cannabinoid (CBD) oil in patients with renal cell carcinoma undergoing systemic therapy. JOURNAL OF CLINICAL ONCOLOGY. 2020.

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

2020

Volume

38

Issue

15

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences